Does highly purified eicosapentaenoic acid increase interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia?
This study is the first to show that EPA increases the monocyte IL-10 expression in parallel with decrease of arterial stiffness, which may contribute to the antiatherogenic effect of EPA in obese dyslipidemic patients.
Health professionals should be aware that obese women may be at increased risk of not breastfeeding or stopping breastfeeding prematurely.